Medidata Named by IDC MarketScape™ as a Leader in Worldwide Life Sciences R&D RWD/RWE Data Platforms, Technology Solutions, and Consulting Services

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeGlobeNewswireThis section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Medidata Named by IDC MarketScape™ as a Leader in Worldwide Life Sciences R&D RWD/RWE Data Platforms, Technology Solutions, and Consulting ServicesAuthor of the article:Medidata is the only company exclusively dedicated to clinical trial technology recognized in the Leaders categoryTHIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountNEW YORK , Oct. 28, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, has been named as a Leader in the most recent IDC MarketScape™ “Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services, 2026” vendor assessment (doc #US54122226, September 2026). Medidata is the only company exclusively focused on the clinical trial space to be placed in the Leaders category, highlighting its comprehensive platform combining AI capabilities, high-quality, longitudinal patient-level data, and real-world data (RWD) / real-world evidence (RWE) workflows.This advertisement has not loaded yet, but your article continues below.“Medidata’s position as a Leader highlights its comprehensive ecosystem for AI-driven real-world data and evidence generation,” said Dr. Nimita Limaye, research vice president, Life Sciences R&D Strategy & Technology, IDC. “Medidata seamlessly combines robust technology solutions, advanced AI capabilities, and clinical data science expertise, equipping sponsor organizations to maximize the ROI of their trial data and bring therapies to market faster.”Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againThe report highlights Medidata’s Clinical Data and Regulatory Innovation (CDRI) team of statisticians and data scientists, who leverage anonymized data from over 42,000 trials and 13 million patients to build external control arms (ECAs) and efficacy benchmarks. Within Medidata’s Study Experience, CDRI sets itself apart through its regulatory expertise, long-term scientific collaborations with Friends of Cancer Research, and invitations to present as ECA experts to both the FDA and EMA. CDRI is well positioned to deliver client analyses and enhance these analyses through regulatory and statistical consulting.This advertisement has not loaded yet, but your article continues below.In addition to clinical data analytics, the Marketscape recognizes Medidata Link within the Data Experience, which allows for prospective clinical trial linkage to real-world data sources to comprehensively understand the patient experience journey, before, during, and after a clinical trial. Medidata Link received a Reagan-Udall Foundation Innovation Award in 2022.The report also specifically calls out how Medidata’s customers recognize the meaningful regulatory and clinical development value in the insights and expertise Medidata’s CDRI team provides, as well as the scalability and functionality of Medidata Link.“Being recognized as a Leader by the IDC MarketScape is a powerful validation of the quality and operational effectiveness of our AI-driven platform,” said Anthony Costello, Medidata CEO. “Our commitment to the clinical trial experience means building solutions that truly perform. By seamlessly integrating real-world data with our advanced solutions and expert services, we are effectively empowering our partners to accelerate clinical breakthroughs and deliver life-saving therapies to patients.”This advertisement has not loaded yet.This advertisement has not loaded yet, but your article continues below.About the IDC MarketScapeThe IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of technology and service suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.About MedidataMedidata has been powering smarter treatments and healthier people by supporting clinical trials through groundbreaking technological innovations for over 25 years. Medidata is a leader in AI-powered solutions across the entire trial lifecycle to accelerate clinical breakthroughs, reduce patient and site burden, and bring new therapies to market faster. Supported by one of the largest clinical datasets in the industry of more than 42,000 trials and 13 million patients, Medidata’s Study, Patient, and Data Experiences are trusted by more than 1 million registered users across approximately 2,300 customers. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and is recognized as a leader by Everest Group and IDC. Discover more at www.medidata.com. Listen to our latest podcast, from Dreamers to Disruptors, and follow us at @medidata-solutions on LinkedIn.This advertisement has not loaded yet, but your article continues below.About Dassault SystèmesDassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. Through the 3DEXPERIENCE agentic platform, AI-powered, science-based virtual twins help 390,000 customers of all sizes, in all industries, collaborate, imagine and create sustainable innovations that drive meaningful impact. For more information, visit: www.3ds.comThis advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.